Biote (BTMD) Liabilities and Shareholders Equity (2020 - 2026)

Biote's Liabilities and Shareholders Equity history runs 7 years deep, the most recent figure standing at $89.0 million for Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity fell 27.84% year-over-year to $89.0 million; the TTM figure through Mar 2026 stood at $412.8 million (down 6.17% YoY), while the FY2025 annual figure was $107.6 million, down 12.06% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $89.0 million, down from $107.6 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $317.9 million in Q1 2022, with the low at $89.0 million in Q1 2026.
• The 5-year median for Liabilities and Shareholders Equity is $115.3 million (2022), against an average of $131.2 million.
• Peak annual rise in Liabilities and Shareholders Equity reached 105.49% in 2022, while the deepest fall reached 65.57% in 2022.
• Biote's Liabilities and Shareholders Equity stood at $111.6 million in 2022, then surged by 39.1% to $155.3 million in 2023, then retreated by 21.2% to $122.4 million in 2024, then decreased by 12.06% to $107.6 million in 2025, then fell by 17.27% to $89.0 million in 2026.
• Business Quant data shows BTMD's Liabilities and Shareholders Equity at $89.0 million in Q1 2026, $107.6 million in Q4 2025, and $111.3 million in Q3 2025.